Gene · 54888
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant KIF26B expression promotes bladder cancer progression through driving NSUN2 nuclear localization. | J Hematol Oncol | 2025 | 41423602 | PubTator, text mining | PubMed |
| Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy. | ACS Nano | 2025 | 41401238 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer. | Cell Death Dis | 2025 | 41354740 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals that ALYREF-mediated m5C modification promotes platinum resistance in ovarian cancer via the NSUN2/ALYREF/LGR4 axis. | Cell Death Dis | 2025 | 41345330 | PubTator, text mining | PubMed |
| Flaviviridae RdRp exploits NSUN2-driven m5C methylation to establish persistent infection. | PLoS Pathog | 2025 | 41343601 | PubTator, text mining | PubMed |
| Correction to 'mRNA turnover dynamics are affected by cell differentiation and loss of the cytosine methyltransferase Nsun2'. | Nucleic Acids Res | 2025 | 41312770 | PubTator, text mining | PubMed |
| One RNA-binding protein, many decisions: integrating the transcript life cycle into neuronal regulation. | Front Mol Neurosci | 2025 | 41311672 | PubTator, text mining | PubMed |
| The Role of mRNA Alternative Processing in Mammalian Neurodevelopment. | Int J Mol Sci | 2025 | 41303558 | PubTator, text mining | PubMed |
| Roles and mechanisms of NSUN2-mediated RNA m5C modification in cancer progression and immune modulation. | Front Immunol | 2025 | 41256859 | PubTator, text mining | PubMed |
| Investigating the causal role of cellular senescence-related genes in preeclampsia: a multi-omics Mendelian randomization study with differential expression analysis. | Front Endocrinol (Lausanne) | 2025 | 41220585 | PubTator, text mining | PubMed |
| HydraRNA: a hybrid architecture based full-length RNA language model. | Genome Biol | 2025 | 41214747 | PubTator, text mining | PubMed |
| METTL1-mediated m7G modification regulates osteogenic differentiation of human periodontal ligament stem cells. | Clinics (Sao Paulo) | 2025 | 41161258 | PubTator, text mining | PubMed |
| Exosome miRNA sorting controlled by RNA-binding protein-motif interactions. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132505 | PubTator, text mining | PubMed |
| mRNA turnover dynamics are affected by cell differentiation and loss of the cytosine methyltransferase Nsun2. | Nucleic Acids Res | 2025 | 41099711 | PubTator, text mining | PubMed |
| Myofibroblast specific knockdown of NSUN2 suppresses cardiac fibrosis post-myocardial infarction. | J Mol Cell Cardiol | 2025 | 41045987 | PubTator, text mining | PubMed |
| Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential. | Viruses | 2025 | 41012587 | PubTator, text mining | PubMed |
| Comprehensive analysis of MGLL as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma. | Front Oncol | 2025 | 40994935 | PubTator, text mining | PubMed |
| Analysis of the Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Interactome. | J Proteome Res | 2025 | 40994299 | PubTator, text mining | PubMed |
| ALYREF inhibits ferroptosis in vascular endothelial cells and improves atherosclerosis by epigenetic modification of CISD1. | Clin Epigenetics | 2025 | 40993735 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C hypermethylation of hsa_circ_0004516 promotes breast cancer brain metastasis by activating AKT signaling. | Noncoding RNA Res | 2025 | 40990002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54888/papers?page=6